These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31653522)

  • 1. SERPINB12 as a possible marker of steroid dependency in children with eosinophilic esophagitis: A pilot study.
    Oliva S; Laudadio I; Fulci V; Rossetti D; Isoldi S; Stronati L; Carissimi C
    Dig Liver Dis; 2020 Feb; 52(2):158-163. PubMed ID: 31653522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical steroids in eosinophilic esophagitis: Systematic review and meta-analysis of placebo-controlled randomized clinical trials.
    Murali AR; Gupta A; Attar BM; Ravi V; Koduru P
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1111-9. PubMed ID: 26699695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets.
    Lu S; Mukkada VA; Mangray S; Cleveland K; Shillingford N; Schorl C; Brodsky AS; Resnick MB
    PLoS One; 2012; 7(7):e40676. PubMed ID: 22815788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.
    Albert D; Heifert TA; Min SB; Maydonovitch CL; Baker TP; Chen YJ; Moawad FJ
    Dig Dis Sci; 2016 Jul; 61(7):1996-2001. PubMed ID: 27093866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 12-Week Maintenance Therapy with a New Prepared Viscous Budesonide in Pediatric Eosinophilic Esophagitis.
    Oliva S; Rossetti D; Papoff P; Tiberti A; Mallardo S; Volpe D; Ruggiero C; Russo G; Vezzoli D; Isoldi S; Cucchiara S
    Dig Dis Sci; 2019 Jun; 64(6):1571-1578. PubMed ID: 30659470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent insights on the use of topical steroids in eosinophilic esophagitis.
    Reddy A; Ashat D; Murali AR
    Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):953-963. PubMed ID: 32567417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment in Patients With Eosinophilic Esophagitis.
    Eluri S; Selitsky SR; Perjar I; Hollyfield J; Betancourt R; Randall C; Rusin S; Woosley JT; Shaheen NJ; Dellon ES
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1081-1088.e2. PubMed ID: 30213583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic and gene expression analysis of initial biopsies from patients with eosinophilic esophagitis refractory to therapy.
    Siddique AS; Corney DC; Mangray S; Lombardo KA; Chen S; Marwaha AS; Resnick MB; Herzlinger M; Matoso A
    Hum Pathol; 2017 Oct; 68():79-86. PubMed ID: 28882697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Every-other-day Dosing of Oral Viscous Budesonide Is not Effective in the Management of Eosinophlic Esophagitis.
    Rubinstein E; Hait EE; Mitchell PD; Lee JJ
    J Pediatr Gastroenterol Nutr; 2018 Mar; 66(3):395-397. PubMed ID: 28837508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic esophagitis--treatment of eosinophilic esophagitis with drugs: corticosteroids.
    von Arnim U; Malfertheiner P
    Dig Dis; 2014; 32(1-2):126-9. PubMed ID: 24603395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis.
    Min SB; Nylund CM; Baker TP; Ally M; Reinhardt B; Chen YJ; Nazareno L; Moawad FJ
    J Clin Gastroenterol; 2017 Feb; 51(2):127-135. PubMed ID: 27479142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Formulation of Oral Viscous Budesonide in Treating Paediatric Eosinophilic Oesophagitis: A Pilot Study.
    Oliva S; Rossetti D; Papoff P; Tiberti A; Rossi P; Isoldi S; Amil Dias J; Lucarelli S; Cucchiara S
    J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):218-224. PubMed ID: 27253660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
    Dohil R; Newbury R; Fox L; Bastian J; Aceves S
    Gastroenterology; 2010 Aug; 139(2):418-29. PubMed ID: 20457157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined and Alternating Topical Steroids and Food Elimination Diet for the Treatment of Eosinophilic Esophagitis.
    Reed CC; Safta AM; Qasem S; Angie Almond M; Dellon ES; Jensen ET
    Dig Dis Sci; 2018 Sep; 63(9):2381-2388. PubMed ID: 29380175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
    Judd LM; Heine RG; Menheniott TR; Buzzelli J; O'Brien-Simpson N; Pavlic D; O'Connor L; Al Gazali K; Hamilton O; Scurr M; Collison AM; Mattes J; Allen KJ; Giraud AS
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G13-25. PubMed ID: 26514775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis.
    Fable JM; Fernandez M; Goodine S; Lerer T; Sayej WN
    J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):26-32. PubMed ID: 28489670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
    Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
    Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
    Munoz-Persy M; Lucendo AJ
    Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis.
    Dellon ES; Sheikh A; Speck O; Woodward K; Whitlow AB; Hores JM; Ivanovic M; Chau A; Woosley JT; Madanick RD; Orlando RC; Shaheen NJ
    Gastroenterology; 2012 Aug; 143(2):321-4.e1. PubMed ID: 22561055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution manometry in patients with eosinophilic esophagitis under topical steroid therapy-a prospective observational study (HIMEOS-study).
    Nennstiel S; Bajbouj M; Becker V; Slotta-Huspenina J; Wagenpfeil S; Schmid RM; Schlag C
    Neurogastroenterol Motil; 2016 Apr; 28(4):599-607. PubMed ID: 26891170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.